The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Captopril-induced Changes in Prostaglandin Production
Open accessAbstract
Captopril is a potent hypotensive agent whose efficacy has hitherto been attributed to its ability to alter either angiotensin II formation or kinin degradation. Our purpose was to examine captopril's acute effect on prostaglandin production, because changes in neither the renin-angiotensin nor the kallikrein-kinin systems appear adequate to account for the fall in arterial pressure. The plasma levels of angiotensin II, kinins, and prostaglandins were determined in response to increasing doses (5, 12.5, and 25 mg) of captopril and these responses were compared with the change in arterial pressure observed in nine supine normal male subjects studied on both a high (200 meq) and low (10 meq) sodium intake.Captopril significantly (P < 0.01) increased the levels of the 13,14-dihydro-15-keto metabolite of prostaglandin E(2) (PGE(2)-M), a potent vasodilator, with similar responses being observed on both a high and a low sodium intake. No significant changes in the plasma levels of 6-keto-prostaglandin F (1)alpha, or thromboxane B(2), the stable products of prostacyclin and thromboxane A(2), respectively, occurred. The depressor response to captopril correlated with the change in PGE(2)-M (r = 0.52, t = 5.44, P < 0.0001). On the other hand, although significant (P < 0.02) decrements in angiotensin II and increments in plasma kinins accompanied the hypotensive response in sodium-restricted subjects, in sodium-loaded subjects where the renin-angiotensin system was suppressed, no change in angiotensin II, and only a modest change in kinins was noted, even though significant (P < 0.01) decrements in diastolic blood pressure occurred (-10+/-2 mm Hg).Thus, changes in depressor prostaglandin production can better account for the hypotensive response to captopril, thereby extending to yet another vasoactive system an influence by this class of drugs and providing a new approach to dissecting the abnormality in the control of vascular tone in patients with hypertension.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
SNEDECOR, G. W. (1939) · Soil Science · doi:10.1097/00010694-193902000-00006 · Cited by 19,359
Ondetti, M. A., Rubin, B., & Cushman, D. W. (1977) · Science · doi:10.1126/science.191908 · Cited by 1,856
INTRARENAL PROSTAGLANDIN RELEASE ATTENUATES THE RENAL VASOCONSTRICTOR ACTIVITY OF ANGIOTENSIN
AIKEN, J. W., & VANE, J. R. (1973) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)29459-9 · Cited by 396
Oral Angiotensin-Converting Enzyme Inhibitor in Long-Term Treatment of Hypertensive Patients
BRUNNER, H. R., GAVRAS, H., WAEBER, B., KERSHAW, G. R., TURINI, G. A., VUKOVICH, R. A., McKINSTRY, D. N., & GAVRAS, I. (1979) · Annals of Internal Medicine · doi:10.7326/0003-4819-90-1-19 · Cited by 356
Hollenberg, N. K., Chenitz, W. R., Adams, D. F., & Williams, G. H. (1974) · Journal of Clinical Investigation · doi:10.1172/jci107748 · Cited by 333
Self-citationArmstrong, J. M., Lattimer, N., Moncada, S., et al. (1978) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1978.tb07014.x · Cited by 278
Converting enzyme inhibition with an orally active compound in hypertensive man.
Bravo, E. L., & Tarazi, R. C. (1979) · Hypertension · doi:10.1161/01.hyp.1.1.39 · Cited by 217
Underwood, R. H., & Williams, G. H. (1972) · PubMed · Cited by 216
Self-citationHaemodynamics of Orally-Active Converting Enzyme Inhibitor (SQ 14225) in Hypertensive Patients
Cody, R. J., Tarazi, R. C., Bravo, E. L., & Fouad, F. M. (1978) · Clinical Science · doi:10.1042/cs0550453 · Cited by 144
A radioimmunoassay for bradykinin in plasma and synovial fluid.
Talamo, R. C., Haber, E., & Austen, K. F. (1969) · PubMed · Cited by 120
Cited by
WRITING COMMITTEE MEMBERS, Hunt, S. A., Abraham, W. T., Chin, M. H., Feldman, A. M., Francis, G. S., Ganiats, T. G., Jessup, M., Konstam, M. A., Mancini, D. M., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.167586 · Cited by 2,251
Hunt, S. A., Abraham, W. T., Chin, M. H., Feldman, A. M., Francis, G. S., Ganiats, T. G., Jessup, M., Konstam, M. A., Mancini, D. M., Michl, K., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.11.013 · Cited by 1,374
Angiotensin-Converting Enzyme Inhibitors
Brown, N. J., & Vaughan, D. E. (1998) · Circulation · doi:10.1161/01.cir.97.14.1411 · Cited by 958
Dzau, V. J., Packer, M., Lilly, L. S., Swartz, S. L., Hollenberg, N. K., & Williams, G. H. (1984) · New England Journal of Medicine · doi:10.1056/nejm198402093100603 · Cited by 428
Self-citationThe cardiac renin-angiotensin system. An appraisal of present experimental and clinical evidence.
Lindpaintner, K., & Ganten, D. (1991) · Circulation Research · doi:10.1161/01.res.68.4.905 · Cited by 422
Metadata
- Authors
- Swartz, S. L., Williams, G. H., Hollenberg, N. K., Levine, L., Dluhy, R. G., & Moore, T. J.
- Venue
- Journal of Clinical Investigation
- Published
- 1980-06-01
- Volume
- 65
- Issue
- 6
- Pages
- 1257-1264
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W1911188572
- Cited by
- 333
- References
- 11
- FWCI
- 16.03
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Captopril-induced Changes in Prostaglandin Production. https://app.cochat.ai/papers/10.1172/jci109788
- The paper
- Swartz, S. L., Williams, G. H., Hollenberg, N. K., Levine, L., Dluhy, R. G., & Moore, T. J. (1980). Captopril-induced Changes in Prostaglandin Production. Journal of Clinical Investigation. https://doi.org/10.1172/jci109788
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.